KÄÄPÄ Biotech was founded in 2018 in Finland to research, develop and commercialize mycological solutions. The startup has grown fast and today, the company is the largest medicinal mushroom grower in the EU. KÄÄPÄ Biotech strives to lead the change within the medicinal mushroom industry towards more responsible, sustainable, transparent and honest practices.
“NutraIngredients Awards is a respected competition within the nutraceutical and food supplement industry. Winning the Start-up category is a great honor for KÄÄPÄ Biotech. We feel that this is a significant recognition for our several years’ work and dedication to change the medicinal mushroom industry standards towards more sustainable and responsible practices,” says Eric Puro, CEO of KÄÄPÄ Biotech.
KÄÄPÄ Biotech has done extensive research on the wide variety of medicinal compounds, or in other words Compounds of Interest (COI), in Chaga (Inonotus obliquus), Reishi (Ganoderma lucidum), Shiitake (Lentinula edodes), Cordyceps (Cordyceps militaris), Lion’s mane (Hericium erinaceus), Maitake (Grifola frondosa) and Turkey tail (Trametes versicolor). The company aims to educate the market of the full-spectrum of compounds present in these mushroom species.
KÄÄPÄ Biotech is the first company in the mushroom product industry to employ ultrasonic-assisted extraction (UAE) technology. The UAE method is used to break the chitin walls of the mushrooms and extract all the essential compounds. Without an extraction process, many compounds of interest would be locked within the chitin wall of the mushrooms and would pass through the human digestive system untapped.
“We have optimized our extraction method to serve the purpose of creating industry-leading, potent and full-spectrum mushroom extracts. Our Ultrasonic-Assisted Extraction technology offers a safer and more efficient way to obtain the Compounds of Interest from mushrooms compared with traditional extraction methods”, says Eric Puro.
The mushroom product industry is currently in high rise and the market is projected to boom in the coming years
Nordic Mushrooms product line matches the high customer demand for premium-quality medicinal mushroom products. The origin of the ingredients used in the food supplement industry is continuously getting more important.
“Our products are 100% of Finnish origin, from the FSC or PEFC certified Finnish birch substrate, to growing of mushrooms as well as processing and manufacturing of the mushroom extracts. We have full traceability and transparency in our process from spore to shipment. Therefore we can guarantee premium quality mushroom extracts to the market”, Eric Puro summarizes.
KÄÄPÄ Biotech announced in November, 2020 a distribution agreement with Nutralliance to North America. Read the Read the press release.
KÄÄPÄ Biotech is a biotechnology company committed to healthier humans and ecosystems. The company researches, innovates and develops novel industry solutions with fungi. KÄÄPÄ Biotech has three subdivisions: KÄÄPÄ Forest, KÄÄPÄ Health and Nordic Mushrooms. KÄÄPÄ Forest manages the largest chaga cultivation network in the world and promotes versatile use of forests. KÄÄPÄ Health manages one of Europe’s largest outdoor mushroom farms and produces organic mushroom extracts. Nordic Mushrooms is a wholesale division of Finnish grown organic mushrooms extracts.